LGJ Files Amicus Brief at the U.S. Supreme Court in Support of the Petitioner in Commil USA v. CiscoJanuary 28, 2015 | Firm News
LGJ is proud to have filed an amicus brief on behalf of The Biotechnology Industry Organization (BIO) in Commil USA v. Cisco, No. 13-896, a case currently accepted for review by the United States Supreme Court on writ of certiorari from the United States Court of Appeals for the Federal Circuit. In Commil, the issue presented is “[w]hether the Federal Circuit erred in holding that a defendant’s belief that a patent is invalid is a defense to induced infringement under 35 U.S.C. § 271(b).” The Biotechnology Industry Organization (BIO) is a trade association representing over 1,100 companies, academic institutions, and biotechnology centers. BIO members are involved in the research and development of biotechnological healthcare, agricultural, environmental, and industrial products. In the healthcare sector alone, the biotechnology industry has more than 370 therapeutic products currently in clinical trials being studied to treat more than 200 diseases. The vast majority of BIO members are small companies that have yet to bring a product to market and attain profitability.